The Augmentation Review

Explainer · August 10, 2026 · 5 min · By Beatriz Holmgren

Over, Under, or In Between: What Implant Pocket Placement Actually Changes

Subglandular, subpectoral, dual plane, subfascial: the pocket a surgeon chooses shapes your result, your recovery, and your long-term risk profile. Here is what the anatomy really dictates.

Over, Under, or In Between: What Implant Pocket Placement Actually Changes

Ask three patients where their implants sit and you may get three different answers: over the muscle, under the muscle, or a vague shrug. Pocket placement is one of the most consequential decisions in breast augmentation, yet it is often reduced to a single sentence in a consultation. This explainer walks through the four main options, the mechanisms behind each, and the trade-offs that actually matter.

The anatomy in plain terms. The breast gland sits on top of the pectoralis major, the fan-shaped chest muscle. Covering that muscle is a thin connective tissue layer called the fascia. An implant can be placed above the muscle and under the gland (subglandular), partially or fully beneath the muscle (subpectoral), under the fascia but above the muscle (subfascial), or in a hybrid position where the upper portion is under muscle and the lower portion is under gland (dual plane). Each pocket changes how much of your own tissue covers the implant, and coverage drives almost everything else.

Subglandular: direct, but demanding of tissue. Placing the implant directly behind the gland gives the most immediate, breast-shaped result. The implant fills the gland from behind, there is no muscle pushing on it, and recovery tends to be faster because the pectoralis is not disturbed. The catch is coverage. In the upper pole of the breast, the only tissue between implant and skin is gland and fat. In slim patients with a pinch thickness under roughly two centimeters, the implant edge can become visible or palpable, and rippling shows more easily, especially with saline or lower-fill devices. Subglandular placement is also associated in long-term registry data with somewhat higher capsular contracture rates, likely because the implant sits closer to ductal tissue and its bacterial flora, one of the leading theorized triggers of contracture.

Subpectoral: more coverage, more compromise. Sliding the implant beneath the pectoralis major adds a layer of muscle over the upper pole. That extra padding softens the transition from chest to breast, reduces visible rippling, and appears to lower contracture risk, possibly because the muscle acts as a barrier and its constant motion may discourage capsule thickening. Mammography interpretation is also generally easier with submuscular placement because more gland is displaced forward of the implant. The costs are mechanical. Recovery is typically more uncomfortable for the first week because muscle fibers are released along the lower border. And because the muscle remains attached above, contracting the pecs, as in a push-up or chest press, can visibly shift or flatten the implant, a phenomenon called animation deformity. For most patients this is a minor cosmetic quirk. For athletes and heavy lifters, it can be a real consideration.

Dual plane: the modern default for many. Most surgeons today use a dual plane technique, which is often what patients mean when they say under the muscle. The upper half of the implant sits beneath the pectoralis for coverage, while the lower border of the muscle is released so the bottom of the implant sits directly behind the gland. Mechanistically, this lets the implant expand the lower pole naturally, reduces the risk of the muscle pushing the implant upward, and helps in patients with mild sagging, where a fully submuscular implant can otherwise sit high while the gland droops in front of it, sometimes called a waterfall deformity. Dual plane comes in graded versions depending on how much muscle is released, tailored to how much lift the lower pole needs.

Subfascial: a middle path with limits. Subfascial placement puts the implant above the muscle but beneath the pectoral fascia. The idea is to gain a thin extra layer of support without muscle-related animation or a harder recovery. The fascia is genuinely thin, often under a millimeter, so the added coverage is modest. It can be a reasonable option for patients with decent natural tissue thickness who want to avoid animation, but it does not solve rippling in very slim patients the way muscle coverage can.

How the decision actually gets made. In practice, the choice comes down to a few measurable factors: the pinch test thickness in the upper pole, the degree of existing sag, implant size and fill type, and lifestyle. A patient with generous natural tissue and no sag can do well subglandular or subfascial. A slim patient with minimal upper pole tissue usually benefits from muscle coverage. A patient with mild droop who does not want a lift is often best served by dual plane. Silicone gel implants, particularly cohesive types, tolerate thinner coverage better than saline, which nudges the calculus.

What placement does not change. Pocket choice does not meaningfully alter implant lifespan, does not eliminate the need for routine monitoring of silicone devices, and does not prevent capsular contracture, it only shifts the odds. It also does not lock you in forever. Pocket conversion during revision surgery is common and well described, though it adds complexity.

The honest summary: there is no universally superior pocket. There is only the pocket that matches your tissue, your device, and your habits. A consultation that includes a pinch test, a discussion of animation, and a clear rationale for the recommended plane is a good sign you are getting individualized planning rather than a one-size answer.

Related reading: Over, Under, or In Between: How Implant Pocket Placement Actually Changes Outcomes.

Further reading: Implant Pocket Plane Selection in Primary Breast Augmentation: A Meta-Analysis and Systematic Review of Complication Profiles (Aesthetic Plast Surg 2026); Pharmacological Approaches for the Prevention of Breast Implant Capsular Contracture (J Surg Res 2022).